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Diagnostic Performance of QUS for Identifying
Osteoporosis in Postmenopausal Turkish Women
Aim: The aims of this study were to evaluate the ability of quantitative ultrasound (QUS) to identify
osteoporosis in postmenopausal women on the basis of dual-energy X-ray absorptiometry (DXA) T-scores, the
best predictor of osteoporotic fractures, and to find a cut-off value for QUS with the optimum sensitivity and
specificity, in order to select postmenopausal women for DXA referral.
Materials and Methods: This study included 116 postmenopausal women attending Adnan Menderes
University Family Medicine Clinic in Aydin. Bone density was measured at the calcaneus using QUS and at
lumbar spine and femoral neck with DXA. Receiver operating characteristic analysis was carried out to
determine the best sensitivity and specificity for QUS T-scores for comparison with the gold standard.
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Results: Mean age of the group was 57.3 ± 8.4 years. According to DXA measurements, 34.5% of the
women were considered osteoporotic and 49.1% osteopenic. There were weak-moderate positive correlations
between QUS measurements and DXA T-scores of lumbar spine and femoral neck (r = 0.231 and r = 0.286,
respectively, P < 0.05). Using DXA as the gold standard, the cut-off value of QUS T-score was -2.2 with
77.5% sensitivity and 50.0% specificity for osteoporosis. The area under the curve for QUS T-scores in
identifying osteoporotic subjects was 0.646 (P < 0.01).
Conclusions: In our population, postmenopausal women with QUS T-score ≤ -2.2 are candidates for referral
for DXA measurements. QUS can be used for stratifying the population into risk groups for osteoporosis and
its use should be encouraged to increase detection of osteoporosis in primary care settings in developing
countries.
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Kantitatif Ultrasonun Postmenopozal Türk Kad›nlar›nda Osteoporoz
Tan›s›ndaki De¤eri
Amaç: Bu çal›ﬂman›n amac›, osteoporotik k›r›klar› saptamada alt›n standart olan DXA T-skorlar› temelinde,
kalkaneal kantitatif ultrasonografi (QUS) yönteminin postmenopozal Türk kad›nlar›nda osteoporoz
saptamadaki etkinli¤ini belirlemek ve QUS T-skoru için optimum duyarl›l›k ve seçicilik sa¤layacak bir kestirim
de¤eri saptayarak DXA’dan en çok yarar görecek populasyonu belirlemektir.
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Yöntem ve Gereç: Çal›ﬂmaya Adnan Menderes Üniversitesi Aile Hekimli¤i Merkezi’ne baﬂvuran 116
postmenopozal kad›n al›nd›. Achilles Express ultrason cihaz› ile kat›l›mc›lar›n önce kalkaneal QUS ölçümleri,
ard›ndan Dual Enerji X-ray Absorbsiyometri (DXA) ile lomber ve femoral Kemik Mineral Yo¤unlu¤u (KMY)
ölçümleri yap›ld›. Alt›n standart ile karﬂ›laﬂt›rmak için en iyi duyarl›l›k ve özgüllü¤ü belirlemek amac›yla receiver
operator characteristic (ROC) analizi yap›ld›.
Bulgular: Grubun yaﬂ ortalamas› 57,3 ± 8,4 y›ld›. DXA ölçümlerine göre kad›nlar›n %34,5’i osteoporotik ve
%49,1’i osteopenik olarak de¤erlendirildi. Lomber ve femoral DXA T-skorlar› ile QUS T-skorlar› aras›nda zay›forta pozitif korelasyon tespit edildi (s›ras›yla r = 0,231 and r = 0,286, P < 0,05). DXA alt›n standart olarak
al›nd›¤›nda QUS’un, T-skor ≤ -2,2 kesim noktas› için osteoporozu saptamadaki duyarl›l›¤› % 77,5, özgüllü¤ü
%50,0 olarak bulundu ve ROC alan› alt›ndaki de¤er 0,646 olarak saptand› (P < 0,01).
Sonuç: QUS T-skorlar› ≤ -2,2’nin alt›nda olan postmenopozal kad›nlar DXA ölçümüne yönlendirilmelidir. QUS
ile KMY belirlenerek popülasyonun osteoporoz aç›s›ndan risk gruplar›na bölünmesi ve gerekli olanlar›n DXA’ya
yönlendirilmesi sa¤lanabilir. Geliﬂmekte olan ülkelerde, birinci basamakta osteoporozun daha çok saptanmas›
amac›yla QUS kullan›m› art›r›lmal›d›r.
Anahtar Sözcükler: osteoporoz; kantitatif ultrason; kemik mineral yo¤unlu¤u; postmenopozal kad›nlar
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Introduction
Postmenopausal osteoporosis (PMO) is a major health
problem that affects millions of women worldwide. PMO
and its consequences can be regarded as a major source
of mortality, morbidity and medical expenditure in the
world. The incidence of osteoporotic fracture in western
countries and also in Turkey is constantly increasing due
to the increase in life expectancy.
Bone mineral density (BMD) measured by dualenergy X-ray absorptiometry (DXA) is the best
predictor of fracture risk, and over the past decade,
DXA has emerged as the gold standard to evaluate
patients at risk for fragility fractures (1-3). However,
DXA is not an optimal tool for population screening
because of cost constraints and limited availability
(4). Low-cost screening methods in order to select
high-risk individuals who are more likely to benefit
from DXA testing are needed. In recent years, a new
diagnostic test using quantitative ultrasound (QUS)
has been developed as an alternative method for noninvasive assessment of skeletal status and fracture
risk. Today, QUS is accepted as an attractive reality as
it
possibly
provides
early
detection
of
postmenopausal women at high risk of fracture (5).
This technique is widely available, radiation-free,
portable, relatively inexpensive and more time-saving
than DXA (6), and these properties make it suitable
for mass screening in primary care. The National
Osteoporosis Risk Assessment (NORA) study,
enrolling over 200,000 women aged 50 years and
older in the U.S., showed that BMD measured with
peripheral techniques, including QUS, was predictive
of fracture risk after 12 months of follow-up (7).
Although results from prospective studies have
shown that low QUS was also an independent risk
factor for hip and other non-spine fractures (8-11),
its accuracy in diagnosing osteoporosis is not clear
yet. Therefore, the aims of this study were to
evaluate the diagnostic performance of QUS in
identifying osteopenia and osteoporosis in
postmenopausal women on the basis of DXA Tscores, and to find a cut-off value for QUS in selecting
postmenopausal women for DXA referral in our
population.
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Materials and Methods
Study Population
One
hundred
twenty-eight
consecutive
postmenopausal women attending Adnan Menderes
University Family Medicine Clinic in Umurlu, Aydin for any
medical reason were included in the study. Patients were
excluded if they had any of the following: rheumatoid
arthritis, other metabolic bone disease, and current or
previous usage of bisphosphonates or hormone
replacement therapy. Informed consent was obtained
from each participant after the general aim of the study
was explained. Permission was obtained from the
Directorate of Health. In 12 cases, QUS instrument did
not work properly due to technical problems, swollen feet
or a poor signal. Finally, a total of 116 postmenopausal
women were included in the study.
Demographic data was collected by trained nurses
using a standard questionnaire with face-to-face
interviews. Subjects were weighed on a digital scale
(SECA, Hamburg, Germany) without shoes and light
clothes; body weight was recorded to the nearest 0.1 kg.
Standing height was measured without shoes to the
nearest 0.5 cm using a portable wall-mounted
stadiometer (SECA). BMI was calculated by using [BMI =
2
weight (kg) / height (m)] formula and women were
grouped as normal, overweight and obese according to
their BMI values (12). All participants had DXA
measurements after completion of the questionnaire and
QUS measurement.
Quantitative Ultrasound (QUS) Measurements
The QUS measurements were carried out using
Achilles Express ultrasound device (Lunar, Madison, WI,
USA) at the left calcaneus. The manufacturer’s reference
population for stiffness index was used to calculate the Tscore. Subjects were classified as normal, osteopenic or
osteoporotic based on the QUS T-scores. Although there
has been no consensus on the T-score cut-offs and
diagnostic categories to be used with QUS, the instrument
used commonly in Turkey also accepts the World Health
Organization (WHO) criteria as cut-off values.
Daily quality control was carried out for ultrasound
systems with acoustic phantoms provided by the
manufacturers. All of the QUS measurements were
performed by the same technician.
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Dual-Energy
Measurements

X-ray

Absorptiometry

(DXA)

Bone density was measured using the DEXA-QDR4000 (Hologic Inc., Waltham, MA, USA) at the lumbar
spine [vertebrae L1-L4 (LS)] and the hip [femoral neck
(FN)] by trained and certified technicians. The same
machine was used on all subjects and quality assurance
phantom scans were carried out to check system
calibration on a daily basis.
T-scores were used to categorize BMD values as
normal (T-score ≥1.0) or indicating osteopenia (T-score
< -1.0 and > -2.5) or osteoporosis (T-score ≤-2.5), as
proposed by a working party of the WHO (13). Subjects
were classified as having osteoporosis if at least one of
the two measurements (lumbar spine or femoral neck)
indicated osteoporosis, and as having osteopenia if at
least one measurement indicated osteopenia but none
indicated osteoporosis.
Data Analysis
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specificity for QUS T-scores to compare to the gold
standard and to find the best cut-off values that would
give the highest sensitivity. Statistical difference was
defined as P < 0.05.

Results
Demographics
The study population consisted of 116 participants
and the characteristics of the women are shown in Table
1. Mean age was 57.3 ± 8.4 years. The majority of
women were married, with low level of education, and
overweight or obese. One in four women was
multiparous (≥4) and mean parity was 3.4 ± 1.2. Of the
total, 19.0% had previous fragility fractures and 14.7%
had family history of fragility fractures. Osteoporotic
women were older, had greater parity and were less
educated than the others.
DXA and QUS Measurements

Data were analyzed using the Statistical Package for
the Social Sciences program (SPSS 13.0). The descriptive
data was given as a mean ± standard deviation (SD).
Pearson’s correlation coefficients were used to examine
the association between QUS parameters, BMD and
demographic features. Parameters were compared
among groups using an analysis of variance (ANOVA).
DXA BMD measurement was used as the gold standard.
Receiver operating characteristic (ROC) analysis was
carried out to determine the best sensitivity and

According to the WHO criteria, 40 women (34.5%)
were considered as osteoporotic, 57 (49.1%) as
osteopenic, and 19 (16.4%) had normal bone mass using
DXA measurement as the gold standard; 32.8% of the
subjects (38/116) had a T-score ≤-2.5 at LS and 17.2%
(20/116) had a T-score ≤-2.5 at FN. According to QUS Tscores, 55 women (47.4%) were in the osteoporotic
group and 57 (49.1%) presented osteopenia. QUS results
were compared with DXA results in Table 2. There was

Table 1. Characteristics of the participants.
Osteoporotic
n = 40

Osteopenic
n = 57

Normal
n = 19

Total
n = 116

Age (year)

61.0 ± 8.3

57.4 ± 7.5**

49.4 ± 5.8

57.3 ± 8.4

BMI (kg/m2)

30.3 ± 5.0

31.5 ± 4.7

30.7 ± 5.2

31.0 ± 4.8

Years of education
Years since menopause
Parity

2.3 ± 2.6*
17.9 ± 9.2*

4.15 ± 3.3
11.7 ± 9.5

4.15 ± 3.5

3.6 ± 3.3

8.0 ± 7.0

13.4 ± 9.7

4.0 ± 1.2*

3.1 ± 1.1

3.0 ± 1.4

3.4 ± 1.2

QUS T-score

-2.8 ± 0.9*

-2.5 ± 1.1**

-2.1 ± 0.8

-2.6 ± 1.0

Spine T-score

-3.1 ± 0.6*

-1.7 ± 0.6**

-0.0 ± 0.6

-1.9 ± 1.2

Femur T-score

-2.2 ± 0.7*

-1.2 ± 0.9**

0.1 ± 0.9

-1.3 ± 1.5

Data is given as mean ± standard deviation
*P < 0.05 compared with the normal and osteopenic groups
**P < 0.05 compared with the normal group
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Table 2. Comparison of QUS and DXA results of the participants according to WHO criteria.
QUS results
DXA

Total
Osteoporosis

Osteopenia

Normal

Spine
Osteoporosis

22

16

0

38 (32.8%)

Osteopenia

24

26

3

53 (45.7%)

9

15

1

25 (21.6%)

57 (49.1%)

4 (3.4%)

116 (100%)

20 (17.2%)

Normal
Total

55 (47.4%)

Hip
Osteoporosis

14

6

0

Osteopenia

26

30

1

57 (49.1%)

Normal

15

21

3

39 (33.6%)

Total

55 (47.4%)

57 (49.1%)

4 (3.4%)

116 (100%)

Spine+hip
Osteoporosis

24

16

0

40 (34.5%)

Osteopenia

25

29

3

57 (49.1%)

6

12

1

19 (16.4%)

57 (49.1%)

4 (3.4%)

116 (100%)

Normal
Total

55 (47.4%)

moderate-weak correlation between QUS and DXA Tscores (LS T-score r = 0.231; FN T-score r = 0.286; P <
0.05).

Table 3. Use of QUS parameters to predict osteoporosis or osteopenia
defined by DXA.
Characteristics

Osteoporosis

Osteopenia

Sensitivity (95% CI)

77.5 (61.5-89.1)

78.4 (68.8-86.1)

Specificity (95% CI)

50.0 (38.3-61.7)

52.6 (28.9-75.5)

PPV

44.9

89.4

NPV

80.9

32.3

ROC Analysis
Using ROC analysis, we identified the cut-off value
that can be used as an optimal agreement between QUS
and DXA. Using DXA as the gold standard, the cut-off
value of QUS T-score was -2.2 with 77.5% sensitivity and
50.0% specificity for osteoporosis. The probability of
women with a positive test result having osteoporosis,
expressed as positive predictive value (PPV), was 44.9%,
and probability of women with a negative test result not
having osteoporosis, expressed as negative predictive
value (NPV), was 80.9%. The chance of a positive test in
the women who had osteoporosis, expressed as positive
likelihood ratio (+ LR), was 1.55 times the chance of a
positive result if the women did not have the disease.
These results are shown in Table 3.
The sensitivity of QUS using DXA as the gold standard
for osteopenia was 78.4% and specificity 52.6%, with a
cut-off point -1.94. PPV and NPV are also shown in Table
3.
306

LR +

1.55

1.65

LR -

0.45

0.41

CI: Confidence interval
PPV: Positive predictive value
NPV: Negative predictive value
LR: Likelihood ratio.

The ROC curves for QUS T-score using the DXA Tscores as the standard method to diagnose osteoporosis
and osteopenia are shown in Figures 1 and 2,
respectively. The area under the curve (AUC) for QUS Tscores in identifying osteoporotic subjects was 0.646 (P
< 0.01) and for identifying both osteoporotic and
osteopenic subjects was 0.678 (P < 0.01).
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Figure 1. ROC curves for QUS T-score in diagnosing osteoporosis using
DXA as the standard.

Figure 2. ROC curves for QUS T-score in diagnosing osteopenia using
DXA as the standard.

Discussion

A screening device may be considered as an effective
method when it minimizes the number of false negatives
while limiting referral to a second level, like DXA.
Therefore, it is indispensable to identify the QUS values
below which further referral is necessary (5). In this
regard, ROC analysis was performed and QUS T-score of
-2.2 was selected as a cut-off point, for an optimal use of
calcaneal QUS as a first-step screening tool that could
identify the majority of subjects with DXA T-score ≤-2.5,
while restricting the number of subjects to be referred
for a further DXA examination. In other words, QUS Tscore ≤-2.2 identifies a sub-group with osteoporosis in
whom further assessment may be justified. In the same
way, a cut-off value of QUS T-score is calculated as -1.94
for identifying osteopenic subjects. Peripheral measures,
for example QUS, may be used as the first step in
diagnosis. If the results indicate a woman is at high risk
of osteoporosis, she could then be referred for DXA for
definitive diagnosis. Data from a large cohort study,
EPIDOS, suggest that such a sequential approach has
similar sensitivity to using DXA alone, but requires fewer
bone density examinations (22). In a very recent study, it
was found that a sequential diagnostic approach, which
uses QUS followed by DXA for women with low QUS
values, prevents a similar number of hip fractures as does

We aimed to evaluate the diagnostic performance of
QUS in identifying osteopenia and osteoporosis in
postmenopausal women on the basis of DXA T-scores and
also to find a cut-off value for QUS for selecting
postmenopausal women for DXA referral in our
population.
We found that 34.5% of the postmenopausal women
had osteoporosis and 49.1% osteopenia according to
DXA T-scores, and these results are concordant with
other European studies (14-15).
It has been reported that calcaneal QUS may have a
useful role in identifying PMO, and that osteoporotic
individuals had lower calcaneal T-scores compared to
normals (16,17,18). In the present study, calcaneal QUS
T-score values were significantly lower in women with
osteoporosis than in their normal counterparts.
Several studies have reported various correlations (r =
0.34-0.87) between QUS values and DXA measurements
of LS and FN (18-21). In this study, we found a weak
correlation between QUS values and femoral and spinal
DXA measurements. Even though these correlations are
statistically significant, they are not enough to be
predictive.
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testing all women with DXA alone, but it reduces the total
number of women treated and total costs (23).
In ROC analysis, the AUCs were not large enough to
predict osteoporosis and osteopenia as defined by DXA. In
our study, sensitivity for predicting DXA-defined
osteoporosis was high for QUS T-scores (77.5%),
whereas specificity was low (50.0%). A recent study
reported that, relative to DXA, QUS was more specific
(83%) than 11 risk factors alone (42%) (24). NPV was
also high for QUS as a predictor of DXA-defined
osteoporosis versus osteopenia. This indicates that a
woman with DXA-defined osteoporosis is unlikely to have
a QUS result in the osteopenic range.
In the present study, QUS identified about 78.4% of
subjects with osteopenia (sensitivity) and about 52.6% of
subjects without osteopenia (specificity). Only about
89.4% of subjects with a positive QUS test had
osteopenia (PPV). Of the subjects with a negative QUS
test, about 32.3% had no osteopenia (NPV). PPV is high
for osteopenia and we can suppose that QUS is much
more useful for screening for postmenopausal women
with osteopenia who are at risk of developing
osteoporosis if no intervention is done.

Turk J Med Sci

In our study, positive likelihood ratio (+ LR) for the
cut-off point of -2.2 was 1.55, meaning that
osteoporosis was 1.55 times more likely to occur in an
osteoporotic woman than in the others. In the studies
held in Thailand and Spain, + LRs were 4.73 and 5.98,
respectively, for QUS of calcaneus in predicting
osteoporosis (25-26). A high + LR and low – LR close to
zero show that the test provides useful information.
The limitation of this study is the small sample size.
However, we calculated a cut-off point together with QUS
T-score for our postmenopausal female population, and
we will take this cut-off into account with other known
risk factors for osteoporosis when considering women
for DXA referral.
Our study shows that QUS can be used for stratifying
the population into risk groups for osteoporosis and that
women with QUS T-score ≤-2.2 are candidates for
referral for DXA measurements. QUS can be used in any
place of convenience for population screening, such as
primary care settings, and its use in developing countries
should be encouraged to increase detection of
osteoporosis.
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